Skip to content

Development of a question prompt list for patients with metastasised lung cancer in Germany

Development of a question prompt list for patients with metastasised lung cancer in Germany - Projekt QPL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00018811
Enrollment
60
Registered
2019-10-28
Start date
2019-11-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer C34

Interventions

Group 1: Interviews with patients/relatives to assess the current state of communication and develop a question prompt list

Sponsors

Thoraxklinik Heidelberg gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients: - patients with metastasised lung cancer in the Thoraxklinik Heidelberg gGmbH - Diagnosis at least 2 months ago - atvleast one consultation about current state of disease in the last 2 month - good German knowledge. Relatives: - relatives of a patient with metastasised lung cancer in the Thoraxklinik Heidelberg gGmbH - regular contact with patient and doctor during the last year - good German knowledge. Doctors/nursing staff: - doctors/nursing staff working in oncology department of Thoraxklinik Heidelberg gGmbH - good German knowledge.

Exclusion criteria

Exclusion criteria: Patients: diagnosis less than 2 months ago or no consultation about current state of disease, other patients than previously described, Age <18 years, no capacity for consent. Relatives: relatives of other than the previously described patients, no contact to patient or doctor during the last year, Age <18 years, no capacity of consent. Doctor/nursing staff: Trainees/interns, guest students, nursing students, <3 months work in Thoraxklinik Heidelberg gGmbH.

Design outcomes

Primary

MeasureTime frame
Need for and development of a question prompt list. The primary outcome is raised by individual interviews and focus groups in the period from November 2019 to March 2020.

Countries

Germany

Contacts

Public ContactTamara Schulte-Vieting

Thoraklinik Heidelberg gGmbH

Schulte-Vieting@stud.uni-heidelberg.de004915787988134

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026